Morgan Stanley
CME icon

Morgan Stanley’s CME Group CME Stock Holding History

Morgan Stanley’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.78B Buy
9,406,843
+1,043,692
+12% +$310M 0.17% 97
2025
Q4 		$2.28B Sell
8,363,151
-539,287
-6% -$147M 0.14% 124
2025
Q3 		$2.41B Sell
8,902,438
-536,400
-6% -$146M 0.15% 126
2025
Q2 		$2.6B Sell
9,438,838
-1,124,021
-11% -$306M 0.17% 106
2025
Q1 		$2.8B Sell
10,562,859
-418,507
-4% -$103M 0.2% 93
2024
Q4 		$2.55B Sell
10,981,366
-109,007
-1% -$25.1M 0.18% 95
2024
Q3 		$2.45B Buy
11,090,373
+4,792,463
+76% +$992M 0.18% 102
2024
Q2 		$1.24B Buy
6,297,910
+801,278
+15% +$166M 0.1% 187
2024
Q1 		$1.18B Sell
5,496,632
-5,405,130
-50% -$1.14B 0.09% 204
2023
Q4 		$2.3B Buy
10,901,762
+6,042,795
+124% +$1.29B 0.1% 188
2023
Q3 		$973M Buy
4,858,967
+1,163,103
+31% +$231M 0.1% 198
2023
Q2 		$685M Buy
3,695,864
+326,783
+10% +$60.4M 0.07% 272
2023
Q1 		$645M Buy
3,369,081
+172,481
+5% +$31.2M 0.07% 275
2022
Q4 		$538M Buy
3,196,600
+634,876
+25% +$110M 0.06% 319
2022
Q3 		$454M Sell
2,561,724
-19,768
-0.8% -$3.91M 0.06% 298
2022
Q2 		$528M Buy
2,581,492
+1,300,619
+102% +$276M 0.07% 273
2022
Q1 		$305M Sell
1,280,873
-80,552
-6% -$18.9M 0.04% 401
2021
Q4 		$311M Buy
1,361,425
+130,296
+11% +$28.7M 0.04% 418
2021
Q3 		$238M Sell
1,231,129
-9,003
-0.7% -$1.82M 0.03% 468
2021
Q2 		$264M Buy
1,240,132
+163,446
+15% +$34.5M 0.03% 445
2021
Q1 		$220M Buy
1,076,686
+176,393
+20% +$34.7M 0.03% 455
2020
Q4 		$164M Buy
900,293
+72,077
+9% +$12.3M 0.03% 534
2020
Q3 		$139M Sell
828,216
-67,536
-8% -$11.4M 0.03% 488
2020
Q2 		$146M Sell
895,752
-705,654
-44% -$126M 0.03% 439
2020
Q1 		$277M Sell
1,601,406
-563,604
-26% -$112M 0.08% 235
2019
Q4 		$435M Buy
2,165,010
+1,356,109
+168% +$278M 0.1% 195
2019
Q3 		$171M Buy
808,901
+55,045
+7% +$11.5M 0.05% 381
2019
Q2 		$146M Sell
753,856
-272,085
-27% -$50.2M 0.04% 437
2019
Q1 		$169M Sell
1,025,941
-159,719
-13% -$28.2M 0.05% 378
2018
Q4 		$223M Buy
1,185,660
+66,952
+6% +$12.4M 0.07% 298
2018
Q3 		$190M Buy
1,118,708
+190,256
+20% +$32M 0.05% 369
2018
Q2 		$152M Sell
928,452
-188,702
-17% -$30.8M 0.04% 417
2018
Q1 		$181M Buy
1,117,154
+65,199
+6% +$10.4M 0.05% 352
2017
Q4 		$154M Buy
1,051,955
+239,791
+30% +$34.2M 0.04% 436
2017
Q3 		$110M Sell
812,164
-188,879
-19% -$23.9M 0.03% 517
2017
Q2 		$125M Sell
1,001,043
-535,605
-35% -$64.1M 0.04% 477
2017
Q1 		$183M Buy
1,536,648
+656,791
+75% +$79M 0.06% 349
2016
Q4 		$101M Buy
879,857
+219,537
+33% +$24.4M 0.03% 533
2016
Q3 		$69M Buy
660,320
+156,147
+31% +$16.3M 0.02% 684
2016
Q2 		$49.1M Buy
504,173
+56,619
+13% +$5.35M 0.02% 806
2016
Q1 		$43M Sell
447,554
-71,056
-14% -$6.46M 0.02% 841
2015
Q4 		$47M Sell
518,610
-372
-0.1% -$35K 0.02% 824
2015
Q3 		$48.1M Sell
518,982
-24,233
-4% -$2.3M 0.02% 808
2015
Q2 		$50.6M Sell
543,215
-85,567
-14% -$7.98M 0.02% 856
2015
Q1 		$59.6M Buy
628,782
+68,368
+12% +$6.33M 0.02% 749
2014
Q4 		$49.7M Buy
560,414
+130,147
+30% +$11M 0.02% 868
2014
Q3 		$34.4M Sell
430,267
-17,835
-4% -$1.34M 0.01% 1037
2014
Q2 		$31.8M Buy
448,102
+10,842
+2% +$763K 0.01% 1073
2014
Q1 		$32.4M Sell
437,260
-197,628
-31% -$14.9M 0.01% 1014
2013
Q4 		$49.8M Buy
634,888
+117,730
+23% +$9.22M 0.02% 738
2013
Q3 		$38.2M Sell
517,158
-1,644,464
-76% -$121M 0.02% 806
2013
Q2 		$164M Buy
+2,161,622
New +$142M 0.08% 279

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Morgan Stanley's CME Position: Q1 2026 in Review

Morgan Stanley increased its CME Group (CME) stake by 12% in Q1 2026, buying an estimated $310M and bringing the position to 9,406,843 shares worth $2.78B. The position accounts for 0.17% of the portfolio, ranked #97.

Morgan Stanley first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.8B in Q1 2025. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Morgan Stanley held 9,406,843 shares of CME Group worth $2.78B as of Q1 2026.
  • Morgan Stanley bought 1,043,692 CME Group shares in Q1 2026, an estimated $310M.
  • CME Group made up 0.17% of Morgan Stanley's portfolio in Q1 2026, its #97 holding.
  • Morgan Stanley first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's CME Group position peaked at $2.8B in Q1 2025.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.